Correspondence

PIP Silicone Gel Breast Implants: Letter from CMO

This letter from Professor Sally Davies, Chief Medical Officer, explains about recommendation from the Medicines and Healthcare Products Regulatory Agency on PIP breast implants.

Document

Dear colleague letter: PIP Silicone Gel Breast Implants

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@dh.gsi.gov.uk . Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This letter from Professor Sally Davies, Chief Medical Officer, explains about recommendation from the Medicines and Healthcare Products Regulatory Agency on PIP breast implants.

Published 23 December 2011